More IPO aspirants are reaching out to IR agencies, prompting these firms to expand their teams and seek professionals with ...

Done well, fractional IR becomes not an outsourced stopgap but an embedded lever in a firm’s capital formation system.

WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”) , a biopharmaceutical company specializing in the development and commercialization ...

ELKO, NV / ACCESS Newswire / September 17, 2025 / Patriot Critical Minerals ("Patriot" or the "Company"), a U.S.-based ...

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Financial Services Virtual ...

Before this appointment, Rosatelli resigned from his position as a Zenvia Board Member. His professional background is ...

Access the playbook now to see how you can elevate your IR strategy for long-term value. Not only can that intelligence go to inform their company’s future disclosures and pre-empt the questions that ...

ResMed has appointed Salli Schwartz as the new Chief Investor Relations Officer, effective April 21, 2025. Schwartz brings over two decades of experience from roles in finance at health tech and ...

Atossa Therapeutics (ATOS) announces it has appointed CORE IR, a strategic investor relations, public relations, and corporate advisory firm, to ...

Frank Territo is the senior VP, chief of staff and director of investor relations for the Bank of Tampa and a 2025 40 Under ...

SEATTLE, Sept. 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ATOS; “Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing new approaches in breast cancer treatment and prevention, ...